MNMitsuko Nakajima

Mitsuko Nakajima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mitsuko Nakajima has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validation of remote collection and quantification of blood Neurofilament light in neurological diseases

    by Annabelle Coleman, Alexiane Touzé, Mena Farag, Marta Pengo, Michael J Murphy, Yara Hassan, Olivia Thackeray, Kate Fayer, Sophie Field, Mitsuko Nakajima, et al.

    Promising blood-based biomarkers of neuropathology have emerged with potential for therapeutic development and disease monitoring. However, these tools will require specialist tertiary services for integration into clinical management. Remote sampling for biomarker assessment could ease the burden of in-person clinical visits for such tests and allow for frequent sampling. Here we evaluated a capillary finger-prick collection for remote quantification of blood neurofilament light (NfL), a common blood-based biomarker evident in various neurological disorders, and other exploratory markers of neuronal injury and neuroinflammation (GFAP, tau). Matched samples from venepuncture and finger-prick were collected and processed into plasma and/or serum to directly compare NfL levels across four different neurological conditions (HD, MS, ALS, PD). Two delayed processing conditions were compared, three- and seven-day delay, simulating ambient shipment. Capillary NfL and GFAP concentrations were equivalent to those in venous blood serum and plasma. Only NfL remained stable after seven-day processing delay. Capillary NfL replicated disease group differences displayed in venous blood. This data supports our finger-prick method for remote collection and quantification of NfL. With the widespread applications for NfL across the spectrum of neurological disorders, this has the potential to transform disease monitoring, prognosis, and therapeutic development within clinical practice and research. Graphical Figure 1


  • Open Access

    Extensive Medullo-Cervicothoracic Lesion in Acute Lymphoblastic Leukemia

    by Mitsuko Nakajima, Mathilde Pauls, Sanjeev Rajakulendran

    Nakajima M, et al. J Clin Neurol. 2022 Jan;18(1):105-107. https://doi.org/10.3988/jcn.2022.18.1.105